Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study

INTRODUCTION: The BEACON study evaluated the efficacy and safety of QVA149, a once-daily dual bronchodilator containing a fixed-dose combination of the long-acting β(2)-agonist (LABA) indacaterol and long-acting muscarinic antagonist (LAMA) glycopyrronium (NVA237), in development for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahl, Ronald, Jadayel, Dalal, Alagappan, Vijay KT, Chen, Hungta, Banerji, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805248/
https://www.ncbi.nlm.nih.gov/pubmed/24159259
http://dx.doi.org/10.2147/COPD.S49615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805248/
https://www.ncbi.nlm.nih.gov/pubmed/24159259
http://dx.doi.org/10.2147/COPD.S49615

Ejemplares similares